3-Tosyl-3-azabicyclo[3.2.0]heptan-6-one, 95.0%, 250mg

3-Iodo-1-phenyl-1h-pyrazole, 97%, 1g

2-Chloro-6-(trifluoromethoxy)benzonitrile, 250mg

4-Methoxybenzyl (1S,2S)-2-((R)-4-((9H-xanthen-9-yl)methyl)-1-(4-methoxybenzyl)-2,5-dioxoimidazolidin-4-yl)cyclopropane-1-carboxylate, 98%, 100mg

Glycyl-D-valine1g

2-(Pyridin-4-yl)-1H-benzo[d]imidazole-6-carboxylic acid, 95.0%, 10g

2'-O,4'-C-Methyleneadenosine, 250mg

3-Fluoro-4-methylbenzeneboronic acid, 99.00%, 10g

1-BOC-3-(HYDROXYMETHYL)-3-(TRIFLUOROMETHYL)PYRROLIDINE, 95.0%, 250mg

N-Tris(hydroxymethyl)methyl-2-aminoethanesulfonic Acid [Good's buffer component for biological research]>98.0%(T)25g

1,4-Bis(trifluoromethyl)benzene>99.0%(GC)500g

5-Bromo-3-methyl-2-pyridinecarbaldehyde, 95.0%, 10g

Colonne capillaire GC ROTI®Cap-1, 30 m, 0,25 mm, 0,10 µm, 1 pièce(s)